MEDISAB

MEDISAB has been active since 2002 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €742,042 and a net result of €83,300. Equity is growing by about 15% per year across the filed financial years. Its solvency ranks better than 95% of 20,612 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).